Mundipharma fills Europe chief post

Mundipharma International, the firm behind pain treatment brands such as OxyContin and Palladone SR, has filled its newly created European comms manager role with Lara Dow.

Dow, who starts on 10 October, will report to European comms director Rob Cohen in a three-strong, Cambridge-based team.

She moves from Mundipharma associate company Napp Pharmaceuticals, where she has worked for more than a decade.

Most recently she has overseen a comms campaign to launch pain treatment BuTrans, touted as its most important product in ten years.

At Mundipharma – which won In-House Team of the Year at this year's Communiqué Awards (PRWeek, 5 August) – she will handle work ranging from brand comms and medical education to issues management and internal comms.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.